TCT 270: The MicroStent® HEAL Post Market Registry - Interim Results of BTK Revascularization and Major Amputation Prevention  

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Bard Medical; Boston Scientific Corporation; Medtronic; Terumo Medical Corporation; Cardiovascular Systems, Inc.; Philips; PQ Bypass; Micromedical Solutions
• Equity/Stock(s)/Options - CardioFlow